Key result
Low concentrations of ROCK and myosin II inhibitors stimulated astrocytoma migration and altered MLC phosphorylation, indicating a biphasic dependence on myosin II activity.
Modulation of myosin II activity and differential regulation of MLC populations are important in determining optimal astrocytoma migration.
Requires caution with low-dose ROCK inhibitors in glioma models; leaves open myosin II modulation as invasion target.
The generation of contractile force mediated by actin-myosin interactions is essential for cell motility. Myosin activity is promoted by phosphorylation of myosin light chain (MLC). MLC phosphorylation in large part is controlled by kinases that are effectors of Rho family GTPases. Accordingly, in this study we examined the effects of ROCK and Rac1 inhibition on MLC phosphorylation in astrocytoma cells. We found that low concentrations of the ROCK inhibitor Y27632 increased the phosphorylation state of the Triton X-100 soluble fraction of MLC, whereas higher concentrations of Y27632 decreased soluble phospho-MLC. These effects of Y27632 were dependent on Rac1. The soluble form of phospho-MLC comprises about 10% of total phospho-MLC in control cells. Interestingly, ROCK inhibition led to a decrease in the phosphorylation state of total MLC, whereas Rac1 inhibition had little effect. Thus, the soluble form of MLC is differentially regulated by ROCK and Rac1 compared with MLC examined in a total cell extract. We also observed that astrocytoma migration is stimulated by low concentrations of the myosin II inhibitor blebbistatin. However, higher concentrations of blebbistatin inhibit migration leading us to believe that migration has a biphasic dependence on myosin II activity. Taken together, our data show that modulation of myosin II activity is important in determining optimal astrocytoma migration. In addition, these findings suggest that there are at least two populations of MLC that are differentially regulated.
No takes yet. Share an insight, caveat, or question.
Salhia et al. (2007) studied Astrocytoma. ROCK and Rac1 inhibition (Y27632) and myosin II inhibition (blebbistatin) vs. Control cells was evaluated on MLC phosphorylation and cell migration. Low concentrations of ROCK and myosin II inhibitors stimulated astrocytoma migration and altered MLC phosphorylation, indicating a biphasic dependence on myosin II activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: